Page last updated: 2024-09-04

rhodioloside and Parkinson Disease, Secondary

rhodioloside has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Sun, CH; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL; Zhuang, J	1

Other Studies

1 other study(ies) available for rhodioloside and Parkinson Disease, Secondary

Article	Year
Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:5 Topics: Animals; Antioxidants; Apoptosis; Female; Glucosides; Male; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phenols; Rats; Rats, Wistar; Wnt Signaling Pathway	2018

Article

Year

Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:5

Topics: Animals; Antioxidants; Apoptosis; Female; Glucosides; Male; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phenols; Rats; Rats, Wistar; Wnt Signaling Pathway

2018